Study of Drug Resistance in Enterobacteriaceae Isolates in a Tertiary Care Hospital

Study of Drug Resistance in Enterobacteriaceae Isolates

Authors

  • Smita Shevade
  • Gopal Agrawal

DOI:

https://doi.org/10.70284/njirm.v4i2.2161

Keywords:

β-lactamase, drug resistance, enterobacteriaceae

Abstract

Background & objectives: Members of the family enterobacteriaceae comprise the most common gram-negative isolates in microbiology laboratories. Amongst these members, multiple antibiotic-resistant isolates including those producing extended spectrum β-lactamases (ESBL) and AmpC β-lactamases (AmpC) have increased steadily. Further, metallo-β-lactamase (MBL) producing strains are also recently detected. Methods: Three hundred enterobacteriaceae isolates were subjected to antibiotic susceptibility testing. ESBL production was tested by CLSI phenotypic confirmatory test and double disk synergy test using amoxiclav-cefotaxime and piperacillin-tazobactam - cefepime. AmpC was tested by cefoxitin-cefotaxime disk antagonism test. MBL was tested by combined disk test. Results: Amongst 300 enterobacteriaceae isolates, 111 were ESBL, 12 AmpC and 30 MBL producers. K. pneumoniae showed maximum drug resistance and β-lactamase production. Interpretation & conclusion: High drug resistance and β-lactamase production is observed in enterobacteriaceae isolates. It is necessary to keep vigilance for the resistant isolates.

References

1. The Enterobacteriaceae. In: Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, Woods GL. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 6th Ed. Philadelphia: Lippincott Williams & Wilkins. 2006: 211-302.
2. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in enterobacteriaceae lacking chromosomal AmpC β-lactamases. J Clin Microbiol 2005; 43: 3110-3.
3. Pitout JDD, Reisbig MD, Venter EC, Church DL, Hanson ND. Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC –lactamases. J Clin Microbiol 2003, 41: 3933-5.
4. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-ß-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol; 2006, 44: 3139-44.
5. Performance standards for antimicrobial susceptibility testing; Twenty second informational supplement. Clinical Labortory Standards Institute (CLSI) 2012.
6. Shobha KL, Ramachandra L, Rao G, Majumder S, Rao SP. Extended spectrum beta-Lactamases (ESBL) in gram negative bacilli at a tertiary care hospital. J Clin Diag Res 2009; 3: 1307-12.
7. Shobha KL, Gowrish Rao S, Sugandhi Rao, Sreeja CK. Prevalence of extended spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella and Citrobacter species and their antimicrobial susceptibility pattern in a tertiary care hospital. Indian Journal for the Practising Doctor 2007; 3: No. 6 (2007-01 - 2007-02).
8. Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, Mehta A. Detection of β-lactamases in nosocomial gram negative clinical isolates. Indian J Med Microbiol 2004; 22: 247-50.
9. Sanders CC, Sanders Jr WE, Goering RV. In vitro antagonism of beta-lactam antibiotics by cefoxitin. Antimicrob Agents Chemother 1982; 21: 968-75.
10. Picao RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE, Gales AC. Metallo-β-Lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol 2008; 46: 2028-37.
11. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40: 3798-3801.
12. Nagshetty K, Channapa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. Infect Dev Ctries 2010; 4: 70-3.
13. Khan MKR, Thukral SS, Gaind R. Evaluation of a modified double-disc synergy test for detection of extended spectrum β-lactamases in AmpC β-lactamase-producing Proteus
mirabilis. Indian J Med Microbiol 2008; 26: 58-61.
14. Palucha A, Mikiewicz B, Hryniewicz M, Gniadkowski M. Concurrent outbreaks of extended-spectrum β -lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 1999; 44: 489-99.
15. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla (NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046-54.
16. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nature Reviews Microbiology 2004; 2: 123-40.

Downloads

Published

2013-04-30

How to Cite

Shevade, S., & Agrawal, G. (2013). Study of Drug Resistance in Enterobacteriaceae Isolates in a Tertiary Care Hospital: Study of Drug Resistance in Enterobacteriaceae Isolates. National Journal of Integrated Research in Medicine, 4(2), 113–117. https://doi.org/10.70284/njirm.v4i2.2161

Issue

Section

Original Articles